I've worked as an employee and entrepreneur in life science informatics for seventeen years for biotech, pharmaceutical, and medical device companies in Denmark, France, and the US. Prior to that I worked in fin tech for ten years developing trading & risk management systems for banks in London and Germany.
I am an early stage investor in a Silicon Valley-based nanopore biosensor company, and am primarily looking to make similar investments in life sciences and medical informatics startups.
Bioinformatics, Fintech, Medical Devices, Genetic Testing
Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herz., Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Faroe Islands, Finland, France, Germany, Gibraltar, Greece, Greenland, Hungary, Iceland, Ireland, Italy, Jersey, Kosovo, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldava, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Svalbard, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, Vatican City, Anguilla, Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Bonaire, Saba, Canada, Caribbean, Cayman Islands, Costa Rica, Cuba, Curacao, Dominica, Dominican Rep, El Salvador, Grenada, Guadaloupe, Guatemala, Haiti, Honduras, Martinique, Mexico, Montserrat, Nicaragua, Panama, Puerto Rico, Saint Barthelemy, Saint Kitts, Saint Lucia, Saint Martin, Saint Pierre, Saint Vincent, Sint Maarten, Trinidad & Toba., Turks & Caicos, USA, Western Sahara
Scietide was a consultancy operating between 2010 and 2015 which I founded to offer software engineering & regulatory guidance to Bay Area life science companies, with a focus on cloud-based technologies. Now defunct since moving to Denmark.
|Registration Date||03 August 2017|
Start your own profile and join the world’s largest angel investment community. It’s free to join and connect with exciting investment opportunities across a broad range of sectors.
It’s easy to create a pitch using our online form. Your pitch can be in front of our 220,544 investors before you know it.